BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN). This multi-year collaboration agreement will advance the development and commercialization of two companion diagnostic programs, bringing SOPHiA GENETICS’s decentralized clinical trial assays and companion […]
Rainer Blair to retire WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a […]
Agreement marks the start of Eppendorf’s planned manufacturing facility in Penang Eppendorf will invest EUR 40 million in the site, with production expected to start in 2028 New facility will produce selected products of the Centrifuges & Instruments portfolio for global laboratory markets Penang, Malaysia – Eppendorf has signed an agreement for a new production […]
LabKey AI lets any user query lab data in plain language, with results reliable enough for regulated scientific work. “AI is only as good as the data and rules beneath it. We have spent years building that foundation. LabKey AI is what that foundation makes possible.” — Michael Gersch, CEO, LabKey SEATTLE, WA, UNITED STATES […]
La Jolla, Calif., & London – The Sanford Burnham Prebys Medical Discovery Institute, a non-profit research center, has selected Cenevo’s Mosaic sample management platform for life sciences to support their biomedical and translational research, including stem cell and drug discovery studies. Cenevo, the specialist in enabling agentic, connected labs, delivers lab management systems, automation, orchestration, data management […]
New strategic collaboration introduces a scalable alternative to traditional LIMS / LIS configuration models—empowering laboratories to accelerate time-to-value while maintaining operational control and regulatory confidence. TUCSON, Ariz. — Clinisys, a global provider of laboratory informatics solutions, today announced a strategic partnership with Decisions, an enterprise low-code and no-code (LCNC) orchestration and automation platform. Together, the […]
Lucid Genomics provides in-kind access to its genomic analysis platform for laboratories participating in global undiagnosed disease genomics program. By providing our platform in-kind, we hope to help reduce barriers to genomic diagnostics and support Genetic Alliance’s efforts to expand equitable access for patients with rare diseases.” — Uira Souto Melo, Co-Founder and CEO at […]
Collaboration with NVIDIA and Google Cloud Provide Additional Tools and Compute Access NEW YORK — Schrödinger, Inc. (Nasdaq: SDGR) today announced the launch of its early access version of Bunsen, its new agentic AI co-scientist that helps researchers understand scientific objectives, develop computational strategies, execute sophisticated molecular discovery workflows and interpret results. By combining AI […]
TUCSON, Ariz. — Clinisys, a global leader in laboratory informatics, today announced the general availability of Clinisys™ Laboratory Solution (CLS) v2025.3, continuing the evolution of its unified platform for scientific and healthcare laboratories. The release extends CLS with enhanced configuration, expanded interoperability, integrated analytics, and governed AI capabilities—helping laboratories simplify operations, improve visibility, and scale […]
Milestone Reflects Deepening Customer Centricity as DNAnexus Continues to Scale its Platform for the World’s Leading Life Sciences Organizations, Accelerating Growth By Global Expansion MOUNTAIN VIEW, Calif. — Today, DNAnexus, the world’s most trusted platform for omics data enablement, announced it has achieved a 90% customer satisfaction score (CSAT) — a milestone underscoring the trust […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
